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In 1937, an unknown neurotropic virus called West 
Nile virus (WNV) was isolated from the blood of a low-
grade febrile woman from northeastern Uganda (Smith-
burn et al. 1940). Afterwards, WNV was detected in 
Africa, the Middle East, Asia and Europe and was as-
sociated mainly with sporadic or size-limited outbreaks 
of WNV fever, which was usually a self-limited and un-
complicated febrile syndrome (Couissinier-Paris 2006). 
However, in the mid-1990s, a major WNV fever epidem-
ic in Europe with a high rate of neurological infections 
occurred in the lower Danube valley and Bucharest ar-
eas in Romania (Tsai et al. 1998). Concomitantly, human 
and animal outbreaks of WNV fever with neurological 
disorders were reported in the old world, which warned 
of the change of WNV fever impact on animal and pub-
lic health (Tber Abdelhaq 1996, Platonov et al. 2001). In 
1999, WNV definitively reemerged as a worldwide major 
public health and veterinarian concern when it was de-
tected in the Western Hemisphere for the first time as the 
cause of human and equine encephalitis outbreaks con-
comitant with extensive mortality in birds in the north-
eastern United States of America (USA) (CDC 1999). The 
virus rapidly spread through North America and towards 
Latin America (Komar & Clark 2006). There have been 
recent reports of serological evidence of WNV activity 
in Colombia (Mattar et al. 2005), Venezuela (Bosch et al. 
2007) and especially Argentina, where anti-WNV anti-
bodies have been detected in birds (Diaz et al. 2008) and 
the virus was isolated for the first time in South America 
from the brains of horses that had died of encephalitis 
(Morales et al. 2006). However, most South American 
countries, including the largest, Brazil, remain without 
reports of WNV infection. Alerted by the periodical out-
breaks of WNV encephalitis in the USA (Lindsey et al. 
2010) and the serological evidence of WNV activity in 
South America, we performed this study.
The Brazilian Pantanal was selected as a suitable 
place for the study of WNV circulation because of the 
following factors: (i) natural foci of WNV infections 
have been mostly described in wetland ecosystems, such 
deltas and flood plains, as reported in France (Joubert et 
al. 1970), Venezuela (Bosch et al. 2007), Romania (Tsai 
et al. 1998) and Italy (Autorino et al. 2002), (ii) the local 
movement of migratory birds (Nunes & Tomas 2008), 
(iii) the unsuccessful efforts of the detection of WNV-
specific antibodies in the free-ranging birds in Brazil-
ian coastal areas (MS 2003, 2004), (iv) the recent detec-
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Despite evidence of West Nile virus (WNV) activity in Colombia, Venezuela and Argentina, this virus has not been 
reported in most South American countries. In February 2009, we commenced an investigation for WNV in mosqui-
toes, horses and caimans from the Pantanal, Central-West Brazil. The sera of 168 horses and 30 caimans were ini-
tially tested using a flaviviruses-specific epitope-blocking enzyme-linked immunosorbent assay (blocking ELISA) for 
the detection of flavivirus-reactive antibodies. The seropositive samples were further tested using a plaque-reduction 
neutralisation test (PRNT90) for WNV and its most closely-related flaviviruses that circulate in Brazil to confirm the 
detection of specific virus-neutralising antibodies. Of the 93 (55.4%) blocking ELISA-seropositive horse serum sam-
ples, five (3%) were seropositive for WNV, nine (5.4%) were seropositive for St. Louis encephalitis virus, 18 (10.7%) 
were seropositive for Ilheus virus, three (1.8%) were seropositive for Cacipacore virus and none were seropositive 
for Rocio virus using PRNT90, with a criteria of ≥ four-fold antibody titre difference. All caimans were negative for 
flaviviruses-specific antibodies using the blocking ELISA. No virus genome was detected from caiman blood or mos-
quito samples. The present study is the first report of confirmed serological evidence of WNV activity in Brazil.
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tion of arbovirus vectors blood-feeding on human and 
equine hosts in the area (Pauvolid-Corrêa et al. 2010a) 
and, finally, (v) the serological evidence of arbovirus ac-
tivity in the area (Iversson et al. 1993), which includes 
St. Louis encephalitis virus (SLEV) (Pauvolid-Corrêa et 
al. 2010b), a species that is antigenically related to WNV 
(Smithburn 1942). In view of these data, the hypothesis 
that the Brazilian Pantanal is one of the most susceptible 
areas to WNV circulation in Brazil (Pauvolid-Corrêa & 
Varella 2008) seemed promising.
The Pantanal is a tropical, seasonal wetland of ap-
proximately 140,000 km2 that is fed by tributaries of the 
upper Paraguay River in the centre of South America, 
which covers mainly Brazilian but also Paraguayan and 
Bolivian territories and is classified as one of the largest 
freshwater wetland ecosystems in the world (Alho 2005). 
The Brazilian Pantanal, which represents 85% of the total 
Pantanal area, is located within the states of Mato Grosso 
do Sul and Mato Grosso in Central-West Brazil, which 
are recognised as South and North Pantanal, respectively 
(Alho et al. 1988). This region is ecologically classified 
into sub-regions according to vegetation, flooding and 
physiography (Silva & Abdon 1988). The Nhecolândia 
sub-region that is situated in South Pantanal is one of the 
largest, comprising approximately one fifth of the total 
area, and is characterised by hundreds of shallow lakes 
that display varying degrees of salinity and coalescence 
with the system during floods (Adámoli 1982).
Recent studies have demonstrated that some croco-
dilian species may be infected by WNV (Steinman et 
al. 2003, Jacobson et al. 2005) and that Alligator mis-
sissippiensis may also have a viremic load that affords 
the infection of blood-feeding Culicidae vectors, which 
suggests that in areas with high population densities of 
these alligators, juvenile individuals could play an im-
portant role in WNV transmission (Klenk et al. 2004). 
Taking these data into account, the unsuccessful efforts 
to detect WNV circulation in the avian hosts in Brazil 
and the widespread, high prevalence of the Crocodilia 
species, Caiman crocodilus yacare, in the Brazilian 
Pantanal (Campos et al. 2005), our strategy was to in-
vestigate the WNV circulation in the potential vectors, 
dead-end hosts and natural secondary amplifying hosts 
through the collection and testing of mosquitoes and se-
rum samples of horses and wild caimans from the Nhe-
colândia sub-region. No morbidity was observed during 
the sampling period and only apparently healthy horses 
and caimans were sampled in the present study.
MATERiALS AND METHoDS
Study area - In February 2009, mosquitoes and blood 
samples from horses and wild caimans were collected in 
six different cattle ranches of the Nhecolândia sub-region 
(18º20’ 19º40’S and 57º14’ 55º00’W) during the rainy sea-
son. Considering the free circulation of mosquitoes, hors-
es and wild caimans in large ranches, sample collections 
for the study were undertaken in a 700-square-kilometre 
(70,000 ha) area (Figure). The collections for this study 
were authorised by the Brazilian Institute of Environment 
and Natural Resources (license IBAMA 18363-1/2009).
Samples collections - Adult mosquitoes were cap-
tured at sites that were randomly selected using CDC 
automatic light traps and manual aspirators while land-
ing to blood-feed on horses and research team members 
as routinely reported. Living mosquito specimens were 
transported to a field laboratory where they were im-
mobilised by chilling and the species were identified 
through direct observation of the morphological char-
acteristics according to the taxonomic keys (Lane 1953, 
Consoli & Lourenço-de-oliveira 1994). The mosquitoes 
were grouped into pools of up to 50 individuals that were 
sorted with respect to trap, site of capture and species 
and they were then stored in liquid nitrogen in the field.
Caimans were captured from sites where a high con-
centration of these animals was observed. The animals 
were seized by boat in lentic systems that were formed 
by intermittent rivers and taken to the banks. All ani-
mals were weighed, measured, gendered, numbered and 
bled before release. The whole procedure was performed 
only with physical restraint and each animal was worked 
and released within 15 min. Caiman blood samples were 
obtained by puncture of the internal jugular vein be-
tween the 1st and 2nd cervical vertebrae as described 
previously (olson et al. 1975).
Blood samples were taken from horses of different 
ages from different ranches. Concomitantly, an inter-
view was conducted with the rural workers of the ranch-
es that were visited who were asked if they had seen 
horses with any abnormality, such as clinical signs that 
involved the central or peripheral nervous system. We 
also collected information about the sex, age and breed 
of the horses that were present. Additional information 
included whether the horse had recently received vac-
cine or medical treatment and whether any horse had 
been moved into or out of South Pantanal. 
Sampling locations of West Nile virus investigation conducted in 
the Pantanal, Brazil.
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Epitope-blocking enzyme-linked immunosorbent 
assay (blocking ELISA) - Caiman and horse sera were 
first screened for flaviviruses-reactive antibodies using 
a blocking ELISA as described previously (Blitvich et 
al. 2003a, c). Briefly, the ability of the sera to block the 
binding of the monoclonal antibody 6B6C-1 to the WNV 
antigen was compared to the blocking ability of negative 
control horse serum. The monoclonal antibody 6B6C-1 
is appropriate to screen for any flavivirus-reactive anti-
body. Data are expressed as relative percentages. Sam-
ples were considered seropositive when the inhibition 
values produced were ≥ 35%.
Plaque-reduction neutralisation test (PRNT) - The 
seropositive sera of the blocking ELISA was sequen-
tially heat-inactivated and submitted to a PRNT90 as de-
scribed previously (Russell et al. 1967). Briefly, two-fold 
dilutions that ranged from 1:10-1:320 of each blocking 
ELISA seropositive sample were tested for their ability 
to neutralise plaque formation by the chimeras SLEV 
and WNV that were derived from highly attenuated Yel-
low fever virus that contain the premembrane-envelope 
(prM-E) and prM-E and envelope protein genes, respec-
tively (Arroyo et al. 2001, Pugachev et al. 2004, Komar 
et al. 2009), and Cacipacore virus (CPCV), Ilheus virus 
(ILHV) and Rocio virus (RoCV), which are the Bra-
zilian flaviviruses that are phylogenetically related to 
WNV (Kuno et al. 1998). Serum was considered serop-
ositive to a virus species when it reduced at least 90% of 
the formation of plaques of this virus at ≥ 1:40 dilutions 
and its neutralising antibody titre was ≥ four-fold greater 
than what was observed for the other tested flaviviruses. 
The WNV seropositive samples were also submitted to 
PRNT90 for Bussuquara virus (BSQV).
Virus isolation - The caiman sera and mosquito sam-
ples were assayed for virus isolation. The caiman serum 
samples at 1:5 dilutions were inoculated into VERo cell 
culture flasks (Stim 1969). The macerated mosquito 
pool suspensions were inoculated into C6/36 cell culture 
flasks (White 1987). The incubated cell flasks were ob-
served during 14 days to look for any evidence of viral 
cytopathic effect (CPE).
Reverse-transcriptase polymerase chain reaction 
(RT-PCR) - The molecular approach was performed in 
all caiman serum samples and the mosquito samples in 
which the inoculated flasks showed CPE in virus isolation. 
These samples were submitted to RNA extraction using a 
commercial kit (QIAamp© Viral RNA Mini Kit QIAGEN, 
USA) in accordance with the manufacturer’s instructions 
and was followed by a generic nested RT-PCR, which se-
quenced for the detection and identification of arbovirus 
members of the Flavivirus and Alphavirus genus, as de-
scribed previously (Sánchez-Seco et al. 2001, 2005).
RESuLTS
Serum samples of 168 horses from four of the six 
studied cattle ranches were sampled. Most of these 
equines were adult, tame, healthy thoroughbreds of the 
Cavalo Pantaneiro breed. All 168 horse sera were first 
tested using the blocking ELISA and 93 (55.4%) were se-
ropositive. When this subset of 93 seropositive samples 
was tested using PRNT90, five (3%) were seropositive 
for WNV, nine (5.4%) were seropositive for SLEV, 18 
(10.7%) were seropositive for ILHV, three (1.8%) were 
seropositive for CPCV, but none were seropositive for 
ROCV, using the criteria of a ≥ four-fold antibody titre 
difference among the five flaviviruses that were assayed. 
All of the WNV-seropositive samples were < 1:10 for 
BSQV (Table). From the remaining 58 (34.5%) blocking 
ELISA seropositive samples, 56 (33.3%) samples were 
considered seropositive for an undetermined flavivirus 
using the < four-fold antibody titre difference and two 
(1.2%) were considered seronegative with titres < 1:10 
for all of the flaviviruses that were assayed by PRNT90.
From the five horses that were seropositive for WNV, 
two horses had dates of birth available and were four and 
five years old at the time of blood collection. All five sero-
positive animals had no history of journey outside South 
Pantanal or WNV vaccination. All WNV-seropositive 
samples were retested for confirmation and the antibody 
serum titres were 1:80 (n = 1), 1:160 (n = 2) and ≥ 1:320 
(n = 2). The sera of these two horses with antibody serum 
titres ≥ 1:320 were retested with higher dilutions and an 
antibody serum titre of 1:320 was confirmed. These five 
WNV-seropositive horses came from three out of the 
four ranches where horses were sampled. 
Concerning SLEV of the nine seropositive horses from 
the four ranches sampled, six had dates of birth available 
with ages that ranged from four-11 years old. All of the 
SLEV-seropositive horses had never left South Pantanal 
and their antibody serum titres ranged from 1:40-≥ 1:320.
of 18 ILHV-seropositive horses, 12 had available 
dates of birth with ages that ranged from three-13 years 
old in animals from all of the ranches where horses were 
sampled. None of these animals had a history of travel and 
their antibody serum titres ranged from 1:40-≥ 1:320.
From the three horses that were seropositive for 
CPCV, two had available dates of birth and were 12 
years old at the time of blood collection. These two ani-
mals were from the same ranch, had never left the re-
gion and had antibody serum titres for CPCV of 1:160. 
Most of the blocking ELISA-seropositive samples had 
antibody titers < 1:10 for RoCV. of the samples with 
antibody titres ≥ 1:10 for ROCV, only one had a titre ≥ 
1:40. Because the antibody titre difference for the other 
flaviviruses assayed was less than four-fold, it was con-
sidered seropositive for an undetermined flavivirus. of 
the 93 blocking ELISA-seropositive horses, 56 (60.2%) 
with titre differences less than four-fold were considered 
seropositive for an undetermined flavivirus. The two 
blocking ELISA-seropositive samples that had serum 
titres < 1:10 for all five flaviviruses assayed were con-
sidered as seronegative in the present study. 
Thirty caiman specimens up to 1.5 m in length were 
captured from two distinct sites of the same ranch. The 
sera from the 30 caimans displayed negative results to 
virus isolation, RT-PCR and blocking ELISA and were 
subsequently not submitted to PRNT90 methods.
A total of 1,204 mosquitoes from 10 species were cap-
tured at 19 sites that were randomly selected on five ranch-
es. Specimens of the following species were captured: 
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Ochlerotatus scapularis, Psorophora albigenu, Sabethes 
albiprivus, Culex declarator, Culex quinquefasciatus, 
Mansonia titillans, Anopheles albitarsis s.l., Psorophora 
ferox, Anopheles triannulatus s.l. and Psorophora ciliata. 
The mosquitoes were grouped into 65 pools of up to 50 
individuals that were sorted with respect to trap, site of 
capture and species. of a total of the 65 mosquito pools 
that were assayed, one (1.5%) pool with 22 specimens 
of O. scapularis exhibited CPE four days post-infection 
(dpi). The same CPE was observed on subsequent pas-
sages by inoculation into new C6/36 cell culture flasks 
four dpi. Nevertheless, despite the CPE, the pool and the 
supernatant from the sequential passages was negative to 
flaviviruses and alphaviruses as measured by RT-PCR.
TABLE 
Plaque-reduction neutralisation test antibody titres for SLEV, ILHV, WNV, RoCV, CPCV and BSQV 
in epitope-blocking enzyme-linked immunosorbent assay-reactive horses which were seropositive 
for a determined species considering the four-fold titre difference criteria
ID Ranch Age Sex Tame Travel SLEVa ILHV WNVa RoCV CPCV BSQV Interpretation
136 B 12 F T N 1:20 1:80 < 1:10 1:20 1:20 - ILHV
140 B 8 F T N 1:20 ≥ 1:160 < 1:10 < 1:10 1:10 - ILHV
145 B 11 F T N 1:40 ≥ 1:320 1:10 1:10 1:80 - ILHV
158 B 6 F T N 1:80 1:10 1:20 < 1:10 1:20 - SLEV
160 B 12 F T N < 1:10 > 1:40 < 1:10 < 1:10 < 1:10 - ILHV
162 B 3 F T N < 1:10 > 1:40 < 1:10 < 1:10 < 1:10 - ILHV
174 B 4 F U N 1:40 < 1:20 < 1:10 < 1:10 1:10 - SLEV
182 B 4 F U N 1:40 < 1:10 < 1:10 < 1:10 < 1:10 - SLEV
183 B 4 F U N 1:10 1:40 < 1:10 < 1:10 1:10 - ILHV
190 A 13 G T N 1:40 ≥ 1:160 < 1:10 < 1:10 < 1:10 - ILHV
194 A 12 G T N 1:20 < 1:40 1:20 1:20 1:160 - CPCV
197 A 13 G T N < 1:10 > 1:40 < 1:10 < 1:10 < 1:10 - ILHV
199 A 12 G T N < 1:10 > 1:40 < 1:10 < 1:10 < 1:10 - ILHV
203 A 12 G T N 1:20 < 1:40 < 1:10 1:20 1:160 - CPCV
207 A 13 G T N < 1:10 1:40 < 1:10 < 1:10 < 1:10 - ILHV
208 A 8 G T N 1:160 1:40 1:20 1:10 1:40 - SLEV
211 A 11 G T N ≥ 1:320 < 1:40 1:10 < 1:10 1:10 - SLEV
214 A 5 G T N 1:20 < 1:40 1:320 < 1:10 < 1:20 < 1:10 WNV
216 A 7 G T N 1:20 ≥ 1:320 1:80 1:20 1:80 - ILHV
220 A 5 G T N 1:160 < 1:40 1:10 < 1:10 < 1:10 - SLEV
241 A 4 G U N < 1:10 ≥ 1:80 < 1:10 < 1:10 < 1:10 - ILHV
250 A 4 G U N < 1:10 < 1:40 1:160 < 1:10 < 1:20 < 1:10 WNV
253 F UNK G T N < 1:10 > 1:40 < 1:10 < 1:10 < 1:10 - ILHV
268 F UNK G T N 1:80 < 1:10 < 1:10 < 1:10 < 1:10 - SLEV
269 F UNK G T N 1:80 < 1:40 1:20 < 1:10 1:20 - SLEV
270 F UNK F T N < 1:10 1:40 < 1:10 < 1:10 < 1:10 - ILHV
271 F UNK S U N 1:10 ≥ 1:160 1:20 < 1:10 1:40 - ILHV
280 F UNK F U N 1:20 < 1:10 1:80 < 1:10 < 1:20 < 1:10 WNV
283 E UNK G T N < 1:10 1:40 < 1:10 < 1:10 < 1:20 - ILHV
285 E UNK G T N < 1:10 < 1:40 1:160 < 1:10 1:20 < 1:10 WNV
290 E UNK G T N < 1:10 1:80 < 1:10 < 1:10 < 1:10 - ILHV
303 E UNK G T N < 1:10 1:10 < 1:10 < 1:10 1:40 - CPCV
305 E UNK G T N ≥ 1:320 < 1:40 1:20 1:10 < 1:10 - SLEV
306 E UNK G T N 1:10 < 1:40 1:320 < 1:10 1:80 < 1:10 WNV
309 E UNK G T N 1:10 1:80 < 1:10 < 1:10 < 1:10 - ILHV
a: chimera; BSQV: Bussuquara virus; CPCV: Cacipacore virus; F: female; G: gelding; ID: identification of animal; ILHV: Ilheus 
virus; N: no travel outside South Pantanal; RoCV: Rocio virus; S: stallion; SLEV: Saint Louis encephalitis virus; T: tamed; 
U: untamed; UNK: unknown; WNV: West Nile virus; -: non-submitted.
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DiSCuSSioN
Flaviviruses serological test result interpretation is 
sometimes complex and requires careful evaluation (Ko-
mar 2001), especially where data from areas of intense 
flaviviruses co-circulation is expected, such as for South 
American countries. Considering the complex cross-reac-
tivity of flaviviruses, several studies have adopted ELISA 
as a screening method followed by more virus-specific 
serological tests, such as PRNT methods (Blitvich et al. 
2003b, Morales-Betoulle et al. 2006, Diaz et al. 2008). In 
the present study, the use of blocking ELISA as a screening 
method followed by PRNT90 for the most related sylvatic 
Brazilian flaviviruses allowed for the detection of specific 
neutralising antibodies to WNV in 3% of the horses tested 
from the Pantanal region for the first time in Brazil. 
Based on the results that were obtained with the 
blocking ELISA, 93 horse sera presented antibodies 
to flaviviruses. When the same sera were tested using 
PRNT90 for SLEV, WNV, ILHV, RoCV and CPCV, ex-
cept for two samples, none had a serum titre < 1:10 for all 
of the flaviviruses that were tested, which disclosed the 
high specificity of the blocking ELISA method. Accord-
ing to our data, in conjunction with the fact that blocking 
ELISA does not require the use of multiple capture anti-
bodies, which designated this test as useful for virtually 
any vertebrate species, the present study corroborated 
the application of blocking ELISA as an efficient screen-
ing method for flaviviruses serosurveys. 
We have searched for the circulation of WNV in a 
country with an intense circulation of other flaviviruses. 
Therefore, to avoid misinterpretation based on serum 
cross-reactions it was necessary to employ a maximum 
specificity PRNT and only consider seropositive sam-
ples that promote a ≥ 90% reduction in the number of 
WNV plaques as has been described previously in South 
and Central American serosurveys (Quirin et al. 2004, 
Mattar et al. 2005). Besides SLEV, RoCV, ILHV and 
CPCV, other Brazilian sylvatic flaviviruses that are 
related to WNV include the BSQV and Iguape virus 
(IGUV) (Kuno et al. 1998). Despite the geographic dis-
persal of BSQV, which is mainly located in the Caribbe-
an and Central America (Gubler et al. 2007), the WNV 
seropositive samples were also submitted to PRNT90 for 
BSQV to minimise potential high-titered cross reaction 
antibodies. However, considering that IGUV was only 
isolated from sentinel mice in the Southeastern Brazil 
(Coimbra et al. 1993) and that serosurveys suggest infre-
quent occurrence of overt infection, in the present study 
IGUV was not included in the PRNT methods. 
To minimise the cross-reaction results in this serosur-
vey to WNV, we considered the seropositivity for WNV 
and for each of the other flaviviruses assayed, only sera 
with a 1:40 monotypic reaction or with an antibody titre 
higher than 1:40 and a four-fold higher to a species than 
its other related flaviviruses that were assayed. Howev-
er, considering these criteria, 56 (60.2%) of the 93 block-
ing ELISA-seropositive samples were seropositive for an 
undetermined flavivirus species. The high prevalence of 
these inconclusive results may be attributed to the cross-
reacting antibodies that are usually observed among 
species of a Japanese encephalitis virus group (JEVG) 
(Tarr & Hammon 1974) and to the original antigenic sin 
phenomenon, where some individuals that are sequen-
tially infected by a heterologous flavivirus species can 
boost antibody levels against the original virus, which 
produces heterologous cross-reacting antibodies (Inouye 
et al. 1984). Considering the similar maintenance cycles 
of the flaviviruses that were assayed together with the 
hypothesis of its co-circulation in the South Pantanal, 
the original antigenic sin phenomenon may have had an 
effect on the difference of antibody titres among the fla-
viviruses that were assayed and some sequential infec-
tions by a heterologous flavivirus species may not have 
been detected. of the 56 horses that were seropositive 
for an undetermined flavivirus species, 13 (23.2%) had 
antibody titres ≥ 1:40 for WNV, nine (69.2%) of which 
had antibody titres ≥ 1:80. Therefore, it is possible that 
the other 13 (7.7%) of the 168 horses that were tested 
had contact with WNV. It is noteworthy that neutralising 
antibody titres are frequently more than two-fold lower 
in PRNT with chimeras WNV and SLEV than with wild 
virus (Pugachev et al. 2004, Komar et al. 2009). There-
fore, it is also quite possible that some low titre WNV 
and SLEV-seropositive samples were not detected. 
The detection of specific neutralising antibodies to 
WNV in 3% of horses tested in the Pantanal region from 
Brazil was reported in this study. This prevalence is 
similar to the values previously reported for horses from 
other countries of Central and South America, such as 
Venezuela, where a prevalence of 4.3% was described 
(Bosch et al. 2007); Colombia, with a prevalence of 9% 
(Mattar et al. 2005), and El Salvador, with the highest 
seropositivity to WNV of 13.7% (Cruz et al. 2005). De-
spite the adoption of the same criteria for the detection 
of WNV-seropositive animals, it is important to note 
the difference of the flaviviruses that were used in the 
PRNT methods that were performed in different areas. 
The CPCV, which is a Brazilian virus of JEVG, 
is as phylogenetically related to WNV as SLEV and is 
even more closely related to WNV than ILHV, BSQV or 
RoCV, which belong to other flavivirus serocomplexes 
(Kuno et al. 1998). Although CPCV is a non-pathogenic 
arbovirus to date, we detected many samples with neutral-
ising antibodies for both CPCV and WNV, which suggest 
that in future serosurveys for WNV and other sylvatic fla-
viviruses to be conducted in Brazil, the investigation for 
CPCV should be included as a differential diagnosis.
The highest seropositivity for ILHV was expected be-
cause the circulation of ILHV in South Pantanal horses 
was reported in the 1990s (Iversson et al. 1993). Although 
RoCV, which is an indigenous Brazilian flavivirus spe-
cies, was the causative agent of an extensive encephali-
tis epidemic in Southeastern Brazil in the 1970s (Tiriba 
et al. 1976), the detection of neutralizing antibodies for 
RoCV nowadays is unusual. our findings corroborate 
this data because except for one sample, all blocking 
ELISA-seropositive horses had PRNT antibody titres < 
1:40 for RoCV. one should be aware that, although phy-
logenetically related to ILHV (Medeiros et al. 2007) that 
presented the highest prevalence in our study, none of the 
horses tested were seropositive for RoCV, which demon-
strates the high-quality specificity of the PRNT assay.
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Based on our serological data, we reported indirect 
evidence that argues for the silent activity of WNV in the 
Brazilian Pantanal. Considering this hypothesis and tak-
ing into account the age available for the seropositive ani-
mals of four and five years old, we can infer that at least 
during the period from 2005-2009, WNV circulated in 
the area. The detection of SLEV-seropositive four-year-
old horses suggested that some were infected by SLEV 
between 2005-2009, which corroborates the recent report 
of the detection of neutralising antibodies to SLEV in 
horses sampled in 2007 in the same area of the present 
study (Pauvolid-Corrêa et al. 2010b). For CPCV, the two 
seropositive horses with available dates of birth were 12 
years old; therefore, the period of probable circulation was 
difficult to determine. The circulation of ILHV in South 
Pantanal was described in the 1990s (Iversson et al. 1993) 
and this putative circulation has remained. However, ac-
cording to the age of our 18 ILHV-seropositive animals, 
we can only deduce that between 2006-2009, ILHV cir-
culated in the area. Although a better estimation of recent 
circulation of these flaviviruses for future surveillance 
should be based on IgM assays, our data suggested the 
viral activity after 2005 of at least three flaviviruses, in-
cluding WNV, in the Brazilian Pantanal.
We encourage further more encompassing surveys 
for WNV in the South Pantanal and other bordering ar-
eas that especially focus on virus isolation to definitively 
confirm the circulation of WNV in the region, and con-
sequently, identify vectors and vertebrate hosts that are 
involved in the virus local maintenance cycle and trans-
mission. Despite of the serological evidence of horse in-
fections by WNV in the Pantanal region presented here, 
morbidity was not observed, which suggests that WNV 
could be circulating through silent enzootic cycles in an 
area with pristine conditions. In fact, WNV has not been 
related to horse disease in most of the South American 
countries with the exception of Argentina (Morales et 
al. 2006). However, WNV is an important cause of en-
cephalitis in horses in the USA and should be considered 
in the future in the differential diagnosis of neurological 
infections in horses from South Pantanal. 
Despite of the small number of caimans that were 
sampled, the negative results obtained using virus iso-
lation, RT-PCR and blocking ELISA suggested that the 
participation of caimans in flaviviruses cycles in South 
Pantanal is improbable. Nevertheless, the high preva-
lence of this crocodilian species in the Pantanal and the 
high concentration that was observed in some remaining 
collections of water during the dry season associated to 
the present data of serological evidence of the activity of 
members of JEVG in the area justify the need of further 
arbovirus investigations in local caimans. 
All mosquito species identified in the present study 
were previously reported in the Nhecolândia sub-region 
(Pauvolid-Corrêa et al. 2010a). Moreover, the non-
detection of Flavivirus and Alphavirus RNA in the O. 
scapularis pool that caused CPE in C6/36 cells implied 
a virus identity that was not related to WNV, SLEV or 
alphaviruses, which would have been indicated by the 
RT-PCR. Further investigations of the other arbovirus 
groups are currently in progress.
Finally, we have reinforced that the Brazilian Panta-
nal is an interesting scenario where sylvatic flaviviruses 
cycles are probably maintained in silent progression in 
a relatively balanced ecosystem. The recently increased 
environmental degradation of this sensitive, complex 
biome could lead to changes in the intricate ecological re-
lationships that disturb natural enzootic arbovirus cycles, 
which potentially favours local arbovirus outbreaks.
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